ORIGINAL RESEARCH

Morphofunctional state of cryopreserved blood cells at moderate low temperature

Vlasov AA1, Andrusenko SF1, Denisova EV1, Elkanova AB1, Kadanova AA1, Melchenko EA1, Sokulskaya NN1, Domenyuk DA2
About authors

1 North Caucasus Federal University, Stavropol, Russia

2 Stavropol State Medical University, Stavropol, Russia

Correspondence should be addressed: Alexander A. Vlasov
Pushkina, 1, Stavropol, 355017, Russia; ur.ufcn@vosalva

About paper

Author contribution: Vlasov АА — study concept, procedure, interpretation of the results; Andrusenko SF — study design, literature review, manuscript writing; Denisova EV, Kadanova AA, Sokulskaya NN — data acquisition; Elkanova AB, Melchenko ЕА — data processing; Domenyuk DA — manuscript editing.

Compliance with ethical standards: the study was approved by the Ethics Committee of the North Caucasus Federal University (protocol No. 002 dated 11 July 2024); all subjects submitted the informed concent to participation in the study.

Received: 2024-07-17 Accepted: 2024-08-25 Published online: 2024-09-17
|

Cryoprotectants enable the long-term storage of biomaterials. Despite progress in cryopreservation, there are a number of problems associated with damage to the cell membranes that result from insufficient efficacy and toxicity of some components. In this regard, it is important to develop non-toxic cryopreservation agents performing well at low temperature. The study was aimed to assess morphofunctional features of blood cells in the lactulose-based cryopreservation agent considering the effects of moderate low temperature (–40 °С). Blood cells (leukocytes, erythrocytes, platelets) collected from 30 conditionally healthy female voluntary donors aged 18–23 years were assessed. The complete blood count test was performed using the Gemalight 1270 automated hematology analyzer. Computerized cytomorphometric assessement was performed using the MECOS-C2 hardware and software complex. The study results showed morphological and functional integrity of blood cells after the 24 h storage at the temperature of–40 °С when added the lactulose-based cryopreservation agent developed: erythrocytes — 85.3 ± 0.30 % (p < 0.05), platelets – 75 ± 0.71 % (p < 0.05), leukocytes – 90.1 ± 0.91% (p < 0.05) of the values reported before freezing. The findings demonstrate the potential of using lactulose as a non-toxic component of cryopreservation systems, which will expand the range of cryopreservation agents used and make it possible to analyze morphofunctional parameters of frozen whole blood samples when conducting large-scale studies.

Keywords: platelets, erythrocytes, leukocytes, cryopreservation, lactulose, moderate low temperature

КОММЕНТАРИИ (0)